WO2015138910A1 - Real time nuclear isotope detection - Google Patents
Real time nuclear isotope detection Download PDFInfo
- Publication number
- WO2015138910A1 WO2015138910A1 PCT/US2015/020461 US2015020461W WO2015138910A1 WO 2015138910 A1 WO2015138910 A1 WO 2015138910A1 US 2015020461 W US2015020461 W US 2015020461W WO 2015138910 A1 WO2015138910 A1 WO 2015138910A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- activity
- eluate
- line
- radioisotope
- kev
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title description 3
- 230000000694 effects Effects 0.000 claims abstract description 277
- IGLNJRXAVVLDKE-OIOBTWANSA-N Rubidium-82 Chemical compound [82Rb] IGLNJRXAVVLDKE-OIOBTWANSA-N 0.000 claims abstract description 114
- 230000005251 gamma ray Effects 0.000 claims abstract description 79
- CIOAGBVUUVVLOB-VENIDDJXSA-N strontium-82 Chemical compound [82Sr] CIOAGBVUUVVLOB-VENIDDJXSA-N 0.000 claims abstract description 65
- GYHNNYVSQQEPJS-YPZZEJLDSA-N Gallium-68 Chemical compound [68Ga] GYHNNYVSQQEPJS-YPZZEJLDSA-N 0.000 claims abstract description 35
- GNPVGFCGXDBREM-FTXFMUIASA-N Germanium-68 Chemical compound [68Ge] GNPVGFCGXDBREM-FTXFMUIASA-N 0.000 claims abstract description 34
- 230000005258 radioactive decay Effects 0.000 claims abstract description 10
- 230000005855 radiation Effects 0.000 claims description 84
- 238000000034 method Methods 0.000 claims description 81
- 238000000084 gamma-ray spectrum Methods 0.000 claims description 43
- 238000010828 elution Methods 0.000 claims description 29
- 239000002699 waste material Substances 0.000 claims description 13
- 229910052701 rubidium Inorganic materials 0.000 claims description 9
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 claims description 9
- 239000004065 semiconductor Substances 0.000 claims description 4
- ZOKXTWBITQBERF-AKLPVKDBSA-N Molybdenum Mo-99 Chemical compound [99Mo] ZOKXTWBITQBERF-AKLPVKDBSA-N 0.000 claims description 3
- QWUZMTJBRUASOW-UHFFFAOYSA-N cadmium tellanylidenezinc Chemical compound [Zn].[Cd].[Te] QWUZMTJBRUASOW-UHFFFAOYSA-N 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 230000001186 cumulative effect Effects 0.000 claims 3
- 230000002285 radioactive effect Effects 0.000 abstract description 4
- 238000002059 diagnostic imaging Methods 0.000 abstract description 3
- 238000001228 spectrum Methods 0.000 description 31
- CIOAGBVUUVVLOB-OIOBTWANSA-N strontium-85 Chemical compound [85Sr] CIOAGBVUUVVLOB-OIOBTWANSA-N 0.000 description 25
- 239000000463 material Substances 0.000 description 24
- 238000005259 measurement Methods 0.000 description 14
- 238000001730 gamma-ray spectroscopy Methods 0.000 description 12
- 238000010586 diagram Methods 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 238000009826 distribution Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 6
- TVFDJXOCXUVLDH-YPZZEJLDSA-N cesium-131 Chemical compound [131Cs] TVFDJXOCXUVLDH-YPZZEJLDSA-N 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229910052732 germanium Inorganic materials 0.000 description 5
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229910052712 strontium Inorganic materials 0.000 description 4
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000002600 positron emission tomography Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000012217 radiopharmaceutical Substances 0.000 description 3
- 229940121896 radiopharmaceutical Drugs 0.000 description 3
- 230000002799 radiopharmaceutical effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- WUAPFZMCVAUBPE-NJFSPNSNSA-N 188Re Chemical compound [188Re] WUAPFZMCVAUBPE-NJFSPNSNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- CIOAGBVUUVVLOB-NJFSPNSNSA-N Strontium-90 Chemical compound [90Sr] CIOAGBVUUVVLOB-NJFSPNSNSA-N 0.000 description 2
- VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 2
- JBLPUHBAIJVVMG-UHFFFAOYSA-N [Rb].[Sr] Chemical compound [Rb].[Sr] JBLPUHBAIJVVMG-UHFFFAOYSA-N 0.000 description 2
- TVFDJXOCXUVLDH-RNFDNDRNSA-N cesium-137 Chemical compound [137Cs] TVFDJXOCXUVLDH-RNFDNDRNSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 238000009206 nuclear medicine Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000011897 real-time detection Methods 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229910001887 tin oxide Inorganic materials 0.000 description 2
- WFKWXMTUELFFGS-RNFDNDRNSA-N tungsten-188 Chemical compound [188W] WFKWXMTUELFFGS-RNFDNDRNSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- MARUHZGHZWCEQU-UHFFFAOYSA-N 5-phenyl-2h-tetrazole Chemical compound C1=CC=CC=C1C1=NNN=N1 MARUHZGHZWCEQU-UHFFFAOYSA-N 0.000 description 1
- 229910014323 Lanthanum(III) bromide Inorganic materials 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- -1 Nal Chemical class 0.000 description 1
- 229910021533 Rubidium-82 chloride Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- TVFDJXOCXUVLDH-OUBTZVSYSA-N cesium-134 Chemical compound [134Cs] TVFDJXOCXUVLDH-OUBTZVSYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- XKUYOJZZLGFZTC-UHFFFAOYSA-K lanthanum(iii) bromide Chemical compound Br[La](Br)Br XKUYOJZZLGFZTC-UHFFFAOYSA-K 0.000 description 1
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical group [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229950009740 molybdenum mo-99 Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- FGDZQCVHDSGLHJ-RYDPDVNUSA-M rubidium-82 chloride Chemical compound [Cl-].[82Rb+] FGDZQCVHDSGLHJ-RYDPDVNUSA-M 0.000 description 1
- IGLNJRXAVVLDKE-IGMARMGPSA-N rubidium-85 atom Chemical compound [85Rb] IGLNJRXAVVLDKE-IGMARMGPSA-N 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- KEAYESYHFKHZAL-BJUDXGSMSA-N sodium-22 Chemical compound [22Na] KEAYESYHFKHZAL-BJUDXGSMSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 229940056501 technetium 99m Drugs 0.000 description 1
- XSOKHXFFCGXDJZ-UHFFFAOYSA-N telluride(2-) Chemical compound [Te-2] XSOKHXFFCGXDJZ-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
- G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
- G01T1/16—Measuring radiation intensity
- G01T1/167—Measuring radioactive content of objects, e.g. contamination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
- G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
- G01T1/16—Measuring radiation intensity
- G01T1/161—Applications in the field of nuclear medicine, e.g. in vivo counting
Definitions
- This disclosure relates to nuclear isotopes and, more particularly, to detecting and quantifying nuclear isotopes.
- PET Positron emission tomography
- the doses of radiopharmaceutical may be injected or infused into a patient prior to or during a PET scan procedure.
- An infused dose of radiopharmaceutical can be absorbed by cells of a target organ of the patient and emit radiation.
- a PET scanner can detect the emitted radiation in order to generate an image of an organ.
- a patient may be injected or infused with rubidium-82 (i.e., 82 Rb).
- rubidium-82 may exhibit similar physiological uptake as potassium and, accordingly, may be taken into the myocardium following potassium pathways.
- Rubidium-82 can be generated for nuclear medicine procedures using a strontium- rubidium generator ( 82 Sr/ 82 Rb generator).
- Rubidium-82 is a radioactive decay product of strontium-82.
- strontium-rubidium generators contain strontium bound to a generator column through which an eluant is flushed during operation. As strontium-82 decays to rubidium-82, the rubidium-82 may release from the generator column and enter the eluant.
- the resulting stream which is called an eluate, can be injected or infused into a patient. Being able to accurately and timely monitor different nuclear isotopes present in the eluate may help ensure the safe and efficacious use of such a radioisotope generator.
- this disclosure is directed to systems and techniques for detecting and quantifying different radioisotopes in a sample under investigation, such as a sample of eluate eluted from a rubidium isotope generator.
- a gamma ray detector is positioned adjacent to a flowing stream of the eluate and used to detect gamma ray emissions emanating from the flowing stream. As the gamma ray detector detects gamma ray emissions, an activity of 82 Rb and/or an activity of 82 Sr in the eluate may be determined in substantially real time.
- an activity of 82 Sr in eluate passing by the detector may be determined sufficiently quickly such that, if an elevated activity of 82 Sr were detected in the eluate, the eluate can be diverted to a waste bottle without being injected into a patient.
- the activity of 82 Rb and the activity of 82 Sr are determined by resolving overlapping gamma ray spectra emitted by two isotopes.
- 82 Rb is known to emit gamma rays in the energy range of 51 1 keV (kilo electron volts) and 776 keV.
- 85 Sr is known to emit gamma rays in the energy range of 514 keV and is related to 82 Sr through an isotope ratio.
- gamma rays emitted in the 511 keV to 514 keV energy range cannot be clearly attributed to either 82 Rb or 85 Sr.
- gamma rays emitted by 82 Rb in the 51 1 keV range can be resolved from gamma rays emitted by 85 Sr in the 514 keV range to rapidly determine the amount of 82 Rb and 82 Sr in a sample.
- a gamma ray detector is positioned downstream from the radioisotope generator, for example adjacent to a flowing stream of eluate, and used to detect gamma ray emissions emanating from the eluate. As the gamma ray detector detects gamma ray emissions, an activity of the daughter radioisotope, the parent radioisotope, and/or another radioisotope in the eluate may be determined.
- a parent radioisotope present in eluate flowing from the radioisotope generator past the gamma detector may have a sufficiently small activity and/or lack gamma emissions such that it is difficult to resolve the parent radioisotope from the daughter radioisotope.
- the daughter radioisotope may be separated from the parent radioisotope before measuring the gamma spectrum emitted by the eluate.
- the eluate is passed across an accumulator structure configured to preferentially bind the parent radioisotope while allowing the daughter radioisotope to flow past the structure.
- a secondary generator column formed of the same or similar material to the column used in the radioisotope generator can be positioned downstream of the radioisotope generator.
- the second generator column may be substantially or entirely devoid of the parent radioisotope (although parent radioisotope may accumulate on the second generator column over time).
- the gamma detector can be positioned to measure gamma emissions emanating from the second generator column, such as liquid in the second generator column and/or flowing through the generator column.
- eluate discharged from the radioisotope generator may initially flow across the structure.
- Parent radioisotope can accumulate (e.g., bind) on the accumulator structure from the eluate as the eluate is flowing across the structure.
- gamma radiation emitted by the eluate can be measured by the gamma detector. Since the activity of daughter radioisotope is typically expected to be significantly greater than the activity of any parent radioisotope present, the gamma radiation measured by the gamma detector can be attributed to the daughter radioisotope and the activity of the daughter radioisotope determined therefrom.
- the accumulator structure can be flushed with eluant to remove residual eluate / daughter radioisotope from the accumulator structure.
- gamma radiation emitted from the accumulator structure and/or eluant in or flowing across the accumulator structure can be measured by the gamma detector. Since the activity of parent radioisotope (or decay products thereof) is typically expected to be greater than the activity of any residual daughter radioisotope present, the gamma radiation measured by the gamma detector can be attributed to the parent radioisotope and the activity of the parent radioisotope determined therefrom.
- an elution system includes a 82 Sr/ 82 Rb generator configured to generate 82 Rb via elution with an eluant, an eluant line configured to supply the eluant to the 82 Sr/ 82 Rb generator, an eluate line configured to receive eluate eluted from the 82 Sr/ 82 Rb generator and convey the eluate to one of a patient line and a waste line, and a gamma ray detector positioned adjacent to the eluate line and configured to detect gamma rays emitted from eluate flowing through the eluate line.
- the example system also includes a controller communicatively coupled to the gamma ray detector and configured to receive data indicative of the gamma radiation emitted by the eluate flowing through the eluate line, determine an activity of 82 Rb in the eluate based on the received data, and determine an activity of 82 Sr and/or 85 Sr based on the received data.
- a controller communicatively coupled to the gamma ray detector and configured to receive data indicative of the gamma radiation emitted by the eluate flowing through the eluate line, determine an activity of 82 Rb in the eluate based on the received data, and determine an activity of 82 Sr and/or 85 Sr based on the received data.
- a method in another example, includes receiving data indicative of nuclear radiation emitted by an eluate eluted from a rubidium isotope generator, determining an activity of 82 Rb in the eluate based on the received data in substantially real time with receipt of the data, and determine an activity of 82 Sr and/or 85 Sr in the eluate based on the received data in substantially real time with receipt of the data.
- a calibration method includes detecting gamma radiation via a gamma ray detector from a first isotope having a known activity and emitting in a region of a 776 keV line of a gamma ray spectrum and determining an efficiency factor for the 776 keV line by dividing a detected activity of the first isotope in the region of the 776 keV line by the known activity for the first isotope.
- the example method also includes detecting gamma radiation via the gamma ray detector from a second isotope having a known activity and emitting in a region of a 51 1 keV line and a 514 keV line of the gamma ray spectrum and determining an efficiency factor for the 511 keV line and the 514 keV line of the gamma ray spectrum by dividing a detected activity of the second isotope in the region of the 51 1 keV line and the 514 keV line by the known activity for the second isotope.
- the example also includes storing the determined efficiency factor for the 776 keV line and the determined efficiency factor for the 511 keV line and the 514 keV in a memory associated with the gamma ray detector.
- an elution system in another example, includes a radioisotope generator, an eluant line, an eluate, line, a gamma ray detector, and a controller.
- the radioisotope generator is configured to release a daughter radioisotope during elution with an eluant thereby producing an eluate containing the daughter radioisotope, the daughter radioisotope being produced from radioactive decay of a parent radioisotope contained within the radioisotope generator.
- the eluant line is configured to supply the eluant to the radioisotope generator.
- the eluate line is configured to receive and convey eluate eluted from the radioisotope generator.
- the gamma ray detector is positioned to detect gamma rays emitted from radioisotopes released by the radioisotope generator, and decay products thereof, and conveyed from the radioisotope generator via the eluate line.
- the controller is communicatively coupled to the gamma ray detector and configured to receive data indicative of the gamma radiation emitted by the radioisotopes released by the radioisotope generator and the decay products thereof.
- the controller is further configured to determine an activity of the daughter radioisotope in the eluate based on the received data and determine an activity of the parent radioisotope in the eluate based on the received data.
- FIG. 1 is a block diagram of an example radioisotope generator system that may generate radioisotopes.
- FIG. 2 is a plot of an example gamma ray spectrum that may be generated using the radioisotope generator system of FIG. 1.
- FIG. 3 is a flow diagram of an example technique that may be used measure the activity of individual isotopes in the radioisotope generator system of FIG. 1.
- FIG. 4 is a flow diagram of an example technique that may be used to calibrate a detector.
- FIG. 5 is a block diagram of another example radioisotope generator system that may generate radioisotopes.
- FIG. 6. is a flow diagram of an example technique that may be used measure the activity of individual isotopes in the radioisotope generator system of FIG. 5.
- the disclosure relates to real time detection and quantification of different radioisotopes in a sample.
- the described systems and techniques can be implemented to detect and quantify any desired radioisotope eluted from a radioisotope generator that releases a daughter radioisotope produced via radioactive decay of a corresponding parent isotope.
- a radioisotope generator can produce a positron emitter, a photo emitter, or a particle emitter for therapy.
- the parent radioisotope is typically bound to a generator column through which an eluant is flushed during operation.
- the parent radioisotope decays, one or more daughter radioisotopes are produced that bind to the generator column less strongly than the parent radioisotope.
- the daughter radioisotope may be released into the eluant flowing through the generator, thereby producing an eluate containing the daughter radioisotope.
- a radioisotope generator system includes a gamma detector positioned downstream of a radioisotope generator.
- the gamma detector may be positioned to receive gamma radiation emanating from a flow pathway through which eluate flows during operation.
- the gamma detector can measure the gamma radiation from the eluate pathway.
- the activity of one or more radioisotopes present in the eluate produced by the radioisotope generator can be quantified based on the magnitude and characteristics (e.g., energy line, decay rate) of the gamma radiation detected by the gamma detector.
- the radioisotope generator system is actively controlled in real time based on the types and/or quantities of radioisotopes detected by the radioisotope generator system.
- the radioisotope generator system may automatically prohibit or allow a patient infusion procedure, as the case may be, based on the types and/or quantities of radioisotopes detected as being present in the eluate produced by the system.
- radioisotope generator systems can be implemented using a variety of different gamma detectors, including liquid cooled gamma detectors, room temperature gamma detectors, solid state gamma detectors, and the like.
- the resolution of the gamma spectrum generated by a gamma detector can vary depending on the type of gamma detector selected for a system and the configuration of hardware and/or software selected to implement the gamma detector.
- the precision and speed of radioisotope measurements made can vary in practice depending on the configuration of the radioisotope generator system and the practical design choices necessary to implement the system taking into account factors such as the operating environment of the system, cost of implementation, and sophistication of the operating personal.
- a system is implemented using a rubidium generator.
- a sample containing one or more radioisotopes is generated via elution with a rubidium generator.
- rubidium-82 generated as a radioactive decay product from strontium-82 may elute into the eluant, generating a radioactive eluate.
- the eluate may contain isotopes besides rubidium-82, with the number and magnitude of the isotopes varying, e.g., based on the operation performance of the generator.
- strontium-82 and/or strontium- 85 may release from the generator and also enter the eluate.
- cesium- 131 may enter the eluate in trace amounts as a contaminant. Accordingly the total amount of radioactivity measured from the eluate may not to be attributable to any one particular isotope but may instead be the sum amount of radioactivity emitted each of the different isotopes in the eluate.
- a technique that can be used to resolve measured radioactivity from an eluate sample so as to determine the amount of measured radioactivity attributable to each of a plurality of different isotopes in the sample.
- the technique may be used to quantify the amount of activity attributable to rubidium-82 in the eluate and the amount of activity of strontium-82 in the eluate, e.g., so as to determine a concentration of the rubidium-82 and strontium-82.
- the quantification of the different activities may be made in substantially real time by measuring the total radioactivity of the eluate, e.g., so that patient dosing and/or radioisotope generator operation can be adjusted in substantially real time.
- the quantification of the different activities may be made without having to wait for one of the isotopes in the eluate (e.g., rubidium-82) to fully decay to distinguish the amount of activities provided by each of a plurality of different isotopes in the eluate.
- the technique involves generating a gamma ray spectrum from gamma rays emitted by an eluate sample and determining an amount of activity associated with different portions of the spectrum.
- rubidium-82 emits radioactive rays at the 51 1 keV line in the gamma ray spectrum and the 776 keV line of the spectrum. Accordingly, by measuring the amount of radioactivity emitted at the 51 1 keV line and the 776 keV line in the spectrum, it can be assumed that the activity at the two lines is attributable to rubidium-82 and the total activity of rubidium-82 determined.
- strontium-85 when strontium-85 is also present, gamma rays emitted by strontium-85 can interfere with accurate determination of rubidium-82.
- Strontium-85 emits radioactive rays at the 514 keV line in the gamma ray spectrum, which is adjacent the 51 1 keV line of rubidium-82.
- most gamma ray detectors cannot provide enough resolution to distinguish between activity emitted at the 511 keV line from the 514 keV line of the spectrum, preventing the amount of activity of rubium-82 at the 511 keV line from being distinguished from the amount of activity of strontium-85 at the 514 keV line.
- the technique may first determine the activity of rubidium-82 at the 776 keV line of the spectrum and then use this activity to determine the corresponding activity of rubidium- 82 at the 51 1 keV line. For example, the technique may determine the activity of rubidium-82 at the 776 keV line of the spectrum and then multiply this activity by a branching intensity factor to determine the activity at the 511 keV line.
- the branching intensity factor may be a factor that relates the activity of rubidium-82 at the 776 keV line to the activity of the isotope at the 511 keV line based on known nuclear properties of rubidium-82.
- the total activity of rubidium-82 can then be determined by summing the determined activity for the 776 keV line with the determined activity for the 511 keV line. Further, with knowledge of the activity of rubidium-82 at the 511 keV line, this activity can be subtracted from the combined activity of rubidium and strontium measured in the 51 1-514 keV region of the gamma ray spectrum to identify the activity of strontium-85. The activity of strontium-82 can further be identified using the activity of strontium-85 and a ratio relating the activity of strontium-85 to the activity of strontium-82. In this manner, the activity of rubidium-82, strontium-85, and/or strontium-82 can be determined in a sample under investigation.
- the respective activities of rubidium-82, strontium-85, and/or strontium-82 can be determined as rapidly as an electronic processing device performing the calculations can receive gamma ray measurement data and process the data.
- the activities may be determined in substantially real time, e.g., such that the activities of rubidium-82 and strontium-82 can be determined substantially simultaneously with measuring total gamma ray emissions emitted by a sample under investigation (e.g., less than 30 seconds after detecting and measuring the total emissions, such less than 10 seconds, less than 5 seconds, less than 2 seconds, or less than 1 second).
- a gamma ray detector may be calibrated prior to use.
- the gamma ray detector may be calibrated to generate calibration factors, which may be referred to as efficiency factors, that are then stored in a memory associated with the gamma ray detector.
- the efficiency factors may or may not be generated prior to installation of the gamma ray detector in a radioisotope generator system containing a generator that generates radioisotopes via elution.
- different efficiency factors may be applied to activity measurements made at different lines in the gamma ray spectrum so as to generate adjusted activity measurement data.
- a calibration technique involves measuring gamma radiation from a first isotope emitting at or around the 776 keV line (e.g., within a range of plus or minus 5 keV) of the gamma ray spectrum and having a known activity.
- the activity measured by the gamma ray detector at or around the 776 keV line may be divided by the known activity of the isotope to generate a first efficiency factor.
- the first efficiency factor may then be applied to subsequent activity measurements made by the gamma ray detector at the 776 keV line to generate adjusted activity measurements for the line.
- the gamma ray detector is used to measure gamma radiation from a second isotope emitting in the region of the 51 1 to 514 keV lines of the gamma ray spectrum and having a known activity.
- the activity measured by the gamma ray detector at or around the 51 1 to 514 keV lines may be divided by the known activity of the isotope to generate a second efficiency factor.
- the second efficiency factor may then be applied to subsequent activity measurements made by the gamma ray detector at the 51 1 to 514 keV lines to generate adjusted activity measurements for the lines.
- activity measurements made for different radioisotope species can be stored and/or used for a variety of purposes in a radioisotope generator system.
- the gamma ray detector may be installed at the same physical location as a 82 Sr/ 82 Rb generator, e.g., as part of an electronically integrated system that receives measurements from the gamma ray detector and also controls operation of the 82 Sr/ 82 Rb generator.
- the gamma ray detector can be positioned to detect gamma radiation emanating from a flowing stream of eluate discharging from the 82 Sr/ 82 Rb generator. Additionally or alternatively, a sample of eluate generated from the 82 Sr/ 82 Rb generator may be stopped in front of the gamma ray detector for a period of time (e.g., to perform periodic linearity / constancy checks on measurements made by the gamma ray detector).
- data generated by the gamma ray detector may be stored in a memory associated with the 82 Sr/ 82 Rb generator and/or electronically transmitted to an offsite location, e.g., for monitoring and/or evaluating the operation of the 82 Sr/ 82 Rb generator.
- a controller operatively coupled to a 82 Sr/ 82 Rb generator system may control operation of the system based on data generated by the gamma ray detector. For example, the controller may compare the activity of one or more individual isotopes to one or more thresholds stored in memory and control operation of the system based on the comparison.
- the controller may initiate a user alert (e.g., a visual, textual, audible user alert), shut down an eluant pump so as to cease generating eluate, and/or control a diverter valve to divert elute from a patient line to a waste line connected to a waste bottle or vice versa in response to determining that a measured activity for an isotope has exceeded a threshold.
- a user alert e.g., a visual, textual, audible user alert
- shut down an eluant pump so as to cease generating eluate
- a diverter valve to divert elute from a patient line to a waste line connected to a waste bottle or vice versa in response to determining that a measured activity for an isotope has exceeded a threshold.
- FIG. 1 is a block diagram illustrating an example radioisotope generator system 10 in which different radioisotopes may be detected and quantified using systems and methods in accordance with the disclosure.
- Radioisotope generator system 10 includes an eluant reservoir 12, an eluant pump 14, a radioisotope generator 16, and a waste bottle 18.
- Eluant pump 14 receives eluant from eluant reservoir 12, pressurizes the eluant, and discharges pressurized eluant into an eluant line 20.
- a first diverter valve 22 controls the flow of eluant to one of a radioisotope generator inlet line 24 and a radioisotope generator bypass line 26.
- Radioisotope generator bypass line 26 bypasses radioisotope generator 16 and can flow directly into a patient line 28, which may be connected to a patient.
- a second diverter valve 30 controls a flow of eluate generated by elution within radioisotope generator 16 to one of the patient line 28 or a waste line 32. Waste line 32 is connected to waste bottle 18.
- radioisotope generator 16 can generate radioisotopes via elution.
- radioisotope generator 16 may be a 82 Sr/ 82 Rb generator containing strontium-82 bound on a support material, such as stannic oxide or tin oxide.
- Rubidium- 82 is a daughter decay product of strontium-82 and binds less strongly to the support material than the strontium.
- the eluant may release rubidium-82 so as to generate an eluate.
- the eluant is a saline (NaCl) solution
- sodium ions in the saline can displace rubidium in the generator so as to elute a rubidium-82 chloride solution.
- radioisotope generator 16 can generate different types of daughter decay products besides rubidium-82.
- the type of daughter decay product produced by radioisotope generator 16 can be controlled by selecting the type of parent radioisotope loaded onto the generator support material.
- radioisotope generators that can be used as radioisotope generator 16 include, but are not limited to, 99 Mo/ 99m Tc (parent molybdenum-99 bound on a support material to produce daughter decay product technetium-99m); 90 Sr/ 90 Y (parent strontium-90 bound on a support material to produce daughter decay product yttrium-90); 188 W/ 188 Re (parent tungsten- 188 bound on a support material to produce daughter decay product rhenium- 188); and 68 Ge/ 68 Ga (parent germanium-68 bound on a support material to produce daughter decay product gallium-90).
- 99 Mo/ 99m Tc parent molybdenum-99 bound on a support material to produce daughter decay product technetium-99m
- 90 Sr/ 90 Y parent strontium-90 bound on a support material to produce daughter decay product yttrium-90
- 188 W/ 188 Re parent tungsten- 188 bound on a support material to produce daughter decay product r
- radioisotope generators that can be used as radioisotope generator 16 include: 42 Ar/ 42 K; ⁇ Ti/ ⁇ Sc; 52 Fe/ 52m Mn; 72 Se/ 72 As; 83 Rb/ 83m Kr; 103 Pd/ 103m Rh; 109 Cd/ 109m Ag; 113 Sn/ 113m In; 118 Te/ 118 Sb; 132 Te/ 132 I; 137 Cs/ 137m Ba; 140 Ba/ 140 La; 134 Ce/ 134 La; 144 Ce/ 144 Pr; 140 Nd/ 140 Pr; 166 Dy/ 166 Ho; 167 Tm/ 167m Er; 172 Hf/ 172 Lu; 178 W/ 178 Ta; 191 0s/ 191m Ir; 194 0s/ 194 Ir; 226 Ra/ 222 Rn; and
- pressurized eluant from eluant reservoir 12 is passed through the radioisotope generator to release the daughter decay product into the eluant and thereby generate an eluate containing the daughter decay product.
- the type of eluant used may be selected based on the characteristics of the parent radioisotope and support material used for radioisotope generator 16. For example, in the case of a 68 Ge/ 68 Ga generator, a hydrochloric acid solution (e.g., 0.1-1 M HC1) as the eluant.
- Radioisotope generator system 10 in the example of FIG. 1 also includes a nuclear radiation detector 34 and a controller 36.
- Detector 34 may be a gamma ray detector that detects gamma rays emanating from eluate generated by radioisotope generator 16.
- Controller 36 may receive data generated by detector 34 indicative of the amount and type (e.g., spectral distribution) of gamma ray radiation detected by 34. Controller 36 may further process the data to determine an activity of different isotopes in the eluate from which detector 34 detected gamma ray emissions, as described in greater detail below. Controller 36 may also manage the overall operation of radioisotope generator system 10, including initiating and controlling patient dosing procedures, controlling the various valves and pump(s) in the system, receiving and processing signals from detector 34, and the like.
- Radioisotope generator system 10 including initiating and controlling patient dosing procedures, controlling the various valves and pump(s) in the system, receiving and processing signals from detector 34, and the like.
- controller 36 may be communicatively coupled (e.g., via a wired or wireless connection) to the various pump(s), valves, and other components of system 10 so as to send and receive electronic control signals and information between controller 36 and the communicatively coupled components.
- the various components of system 10 may be contained on and/or within a radioisotope generator cart, such as a cart having the configuration described in US Patent No.
- radioisotope generator system 10 can be mounted on a movable cart (e.g., having a base frame on which the components of the system are mounted and wheels) so as to be movable about an operating room in which an infusion procedure is being performed.
- a movable cart e.g., having a base frame on which the components of the system are mounted and wheels
- detector 34 is positioned to detect radiation emitted from eluate at a location between a discharge of radioisotope generator 16 and second diverter valve 30.
- detector 34 is illustrated as being positioned to detect radiation emitted by eluate flowing through radioisotope discharge line 38.
- Detector 34 may be positioned in close proximity to discharge line 38 to detect radiation emanating from eluate in the line, such as adjacent to and, in some examples, in physical contact with an outer surface of the discharge line.
- detector 34 may be positioned less than 5 inches from an outer surface of discharge line 38, such as less than 2 inches, less than 1 inch, less than 1/4 of an inch, or less than 1/32 of an inch.
- detector 34 may not be positioned to detect radiation from eluate in discharge line 38 but may be positioned to measure radiation at other locations within system 10. For example, as described with respect to FIG. 5, detector 34 may be positioned to detect radiation from an accumulator structure positioned downstream from radioisotope generator 16.
- detector 34 can detect gamma ray emissions emanating from a sample of eluate flowing through and/or stopped within discharge line 38.
- Detector 34 may include a variety of different components to detect and process gamma ray radiation signals, such as a pulse sorter (e.g., multichannel analyzer), amplifiers, rate meters, peak position stabilizers, and the like.
- detector 34 comprises a scintillation detector.
- detector 34 comprises a solid-state semiconductor detector.
- detector 34 is a scintillator-type detector, such as a comparatively low-resolution alkali halide (e.g., Nal, Csl) or bismuth germanate (e.g., Bi4Ge3012, or BGO). In other applications, detector 34 incorporates a higher-Z metallic species.
- detector 34 may be a cerium- doped lanthanum, such as LaC13(Ce) or LaBr3(Ce).
- detector 34 is a solid-state semiconductor-type detector, such as a planar germanium detector.
- detector 34 may be a solid-state semiconductor-type telluride detector, such as cadmium-telluride or cadmium-zinc -telluride semiconductor detector.
- Detector 34 may be operated at room temperature or may be cooled below room temperature (e.g., by a cooling device incorporated into radioisotope generator system 10) to increase the resolution of detector.
- Detector 34 can generate gamma ray spectroscopy data.
- the detector may include a passive material that waits for a gamma interaction to occur in the detector volume.
- Example interactions may be photoelectric effects, Compton effects, and pair production.
- a gamma ray undergoes a Compton interaction or pair production for instance, a portion of the energy may escape from the detector volume without being absorbed so that the background rate in the spectrum is increased by one count. This count may appear in a channel below the channel that corresponds to the full energy of the gamma ray.
- a voltage pulse produced by detector 34 can be shaped by a multichannel analyzer associated with the detector.
- the multichannel analyzer may take a small voltage signal produced by the detector, reshape it into a Gaussian or trapezoidal shape, and convert the signal into a digital signal.
- the number of channels provided by the multichannel analyzer can vary but, in some examples, is selected from one of 512, 1024, 2048, 4096, 8192, or 16384 channels. The choice of the number of channels may depend on the resolution of the system, the energy range being studied, and the processing capabilities of the system.
- Data generated by detector 34 in response to detecting gamma ray emissions may be in the form of a gamma ray spectrum that includes peaks.
- the peaks may correspond to different energy levels emitted by different isotopes within an eluate sample under analysis. These peaks can also be called lines by analogy to optical spectroscopy.
- the width of the peaks may be determined by the resolution of the detector, with the horizontal position of a peak being the energy of a gamma ray and the area of the peak being determined by the intensity of the gamma ray and/or the efficiency of the detector.
- FIG. 2 is a plot of an example gamma ray spectrum that may be generated in response to measuring gamma ray radiation emitted by an eluate generated via a 82 Sr/ 82 Rb generator.
- the gamma ray spectrum includes a first peak 50 in the energy range of 500-520 keV and a second peak 52 in the energy range of 760-780.
- Eluate generated using a 82 Sr/ 82 Rb generator may be expected to have some amount of strontium-85 as well as some amount of rubidium-82.
- Rubidium-82 is known to emit gamma radiation at two different energy ranges: the 51 1 keV line and the 776 keV line. Further, strontium-85 is known to emit gamma radiation at the 514 keV line.
- the first peak 50 in the spectrum may represent the combined amount of gamma radiation emitted by the 51 1 keV line of rubidium-82 as well as the 514 keV line of strontium-85.
- the second peak 52 in the spectrum may represent the amount of gamma radiation emitted by the 776 keV line of rubidium-82.
- the first peak 50 may reveal itself as a single, unbroken peak encompassing both the 511 keV and 514 keV energy lines. This may occur when the resolution of the detector is below the resolution required to separately resolve the 51 1 keV line and the 514 keV line. In practice, few commercially available detectors can suitably resolve the 511 keV line from the 514 keV so that first peak 50 reveals itself as two separate peak, one of which encompasses the 511 keV line and the other of which encompasses the 514 keV energy line.
- FIG. 3 is a flow diagram of an example technique that may be used to resolve interfering gamma ray emissions to determine activities for each of a plurality of radioisotopes in a sample under analysis.
- the technique of FIG. 3 may be used by radioisotope generator system 10 of FIG. 1 to determine an activity of strontium- 82, an activity of strontium-85, and/or an activity of rubidium-82, among other isotopes, in a sample of eluate generated by radioisotope generator 16.
- controller 36 receives gamma ray spectroscopy data from detector 34 indicative of the gamma radiation (e.g., magnitude, distribution) detected by detector 34 from the eluate (100).
- Detector 34 may detect, and controller 36 may receive, the gamma radiation as the eluate flows through discharge line 38.
- eluant pump 14 may pump eluant through radioisotope generator 16 at a rate ranging from 25 ml/min to 75 ml/min (e.g., 50 min/min), resulting in an eluate flow rate ranging from 25 ml/min to 75 ml/min.
- Detector 34 may continuously detect gamma rays emitted by eluate flowing through discharge line 38 at this rate. As the concentration of radioisotopes in the eluate change, detector 34 may detect changing gamma radiation from the eluate.
- detector 34 does not detect radiation from a flowing source of liquid isotopes but rather from a static volume of isotopes.
- eluate may be statically positioned in front of detector 34 (e.g., by closing second diverter valve 30) so as to hold a non-moving volume of eluate in front of the detector. This may be useful, e.g., to perform periodic linearity / constancy checks on the system.
- controller 36 may determine an amount of activity associated with second peak 52 (FIG. 2) and the 776 keV line of the spectrum (102).
- activity may be reported in Becquerel (Bq) or Curie (Ci) and is a function of the composition of a particular isotope and the
- controller 36 may identify a region of interest encompassing the 776 keV peak and integrate the area under the peak.
- the region of interest may be a region defined between two different energy lines that includes the peak of interest and bounds the region under which the peak area is integrated to determine corresponding activity.
- the peak when a peak is formed in the gamma ray spectrum (e.g., representing a specific radionuclide), the peak may reside in the continuum and include events in the continuum just under the peak. This energy region of the peak including continuum events is generally called the region of interest.
- the beginning and end points of the region of interest can be determined by using an algorithm performing a second derivative function or, if enough statically significant data is available, by visual inspection of a spectrum.
- the continuum within the region of interest may be subtracted from all the events in the peak. This operation (subtracting the continuum from all events in the peak) is referred to as calculating the net peak integral and may be performed by controller 36.
- FIG. 2 shows second peak 52 having a region of interest 54 extending above the continuum 56 and first peak 50 having a region of interest 58 extending above the continuum.
- photo peak usually just called peak
- scattered events primarily from Compton scattering, occur because full absorption of the photon energy did not take place in the detector and these less-than-full energy events are observed from the highest peak energy to the lowest energy in the spectrum. This nearly smooth curve of events running through the spectrum is typically called the continuum.
- the continuum is also referred to as the background, which may be subtracted by controller 36 for the purpose of calculating activity.
- controller 36 can determine the net peak integral count in the region of interest encompassing the 776 keV peak (102). Controller 36 can store this determined activity as the activity of the 776 keV line of rubidium-82 in a memory associated with the controller (104). Subsequently, controller 36 can determine an activity of the 511 keV line of rubidium-82 based on the determined activity of the 776 keV line of the isotope and branching intensity factor (106). Gamma radiation emitted by rubidium-82 is known to branch between the 511 keV line and the 776 keV line at a known ratio.
- This ratio which may be referred to as a branching intensity factor, can be stored in a memory associated with controller 36.
- the branching intensity factor of rubidium-82 is typically reported as being approximately 1 : 13 for the 776 keV line / 511 keV line.
- controller 36 may multiply the activity determined for the 776 keV line of rubidium-82 by the branching intensity factor (e.g., 13).
- Controller can then store this determined activity as the activity of the 511 keV line of rubidium-82 in a memory associated with the controller (108).
- controller 36 determines a total amount of activity for rubidium-82 in the eluate sample under investigation by summing the determined activity for the 776 keV line of the rubidium with the determined activity for the 51 1 keV line (1 10).
- the example technique of FIG. 3 further includes determining an amount of activity associated with first peak 50 (FIG.2) and the 511-514 keV lines of the spectrum (112). Controller 36 can identify a region of interest encompassing the 51 1-514 keV peak, as discussed above with respect to the 776 keV peak, and determine the net peak integral count for the identified region of interest. Once controller 36 identifies the amount of activity associated with the 511-514 keV lines ofthe spectrum, the controller can determine the amount of strontium-85 in the eluate based on the determination (1 14).
- the amount of activity in the first peak 50 encompassing the 511 keV and 514 keV lines may be the combined activity from the 51 1 keV line of rubidium-82 and the 514 keV line of strontium-85. Controller 36 may subtract the amount of activity determined for the 511 keV line of rubidium-82 (e.g., as described with respect to step 106 of FIG. 3) from the total amount of activity determined for the 511-514 keV lines of the spectrum (114). Controller 36 can store the resulting value as the activity of rubidium-85 in the eluate under investigation.
- controller 36 further determines an activity of strontium-82 based on the determined activity of strontium-85 (116).
- the activity of strontium-82 is related to the activity of strontinum-85 by a known isotope ratio, which may be stored in memory associated with controller 36.
- Controller 36 can determine the activity of strontium-82 by multiplying the activity of strontium-85 by the stored ratio to determine the activity of strontium-82 in the eluate.
- controller sums the determined activity of strontium-85 with the determined activity of strontium-82 to identify the total amount of strontium activity in the eluate (1 18).
- controller 36 can identify the amount of activity associated with other isotopes in the eluate based on the gamma ray spectroscopy data received from detector 34 (120). Controller 36 can identify region(s) of interest encompassing other peaks in the spectrum and determine a net peak integral count for the peak(s). Each peak may correspond to a particular radioisotope, and the correspondence between different peaks and different isotopes may be stored in a memory associated with the controller.
- controller 36 may identify an amount of activity provided by cesiuim-131 in the eluate (if any). Cesium- 131 emits gamma radiation at the 32 keV line and may be a contaminant in the eluate. Controller 36 can identify a region of interest encompassing the 32 keV peak and determine the net peak integral count for the identified region of interest to determine the amount of activity associated with cesium- 131.
- the detector may be calibrated.
- the detector may be calibrated periodically in use in system 10 and/or calibrated prior to installation and use in the system (e.g., at a facility that is physically remote from the facility where system 10 resides).
- FIG. 4 is a flow diagram of an example technique that may be used to calibrate a detector, such as detector 34, which is subsequently used in radioisotope generator system 10.
- an isotope having a known activity and emitting gamma radiation at or around the 776 keV line (e.g., within a range of plus or minus 5 keV) of the spectrum is positioned before detector 34 so that the detector detects the emitted radiation (150).
- the isotope is liquid cesium- 134, which emits at the 774 keV line of the spectrum.
- the isotope may be statically positioned before the detector for a period of time or may be flowed past the detector.
- detector 34 when detector 34 is going to be used to measure radioactivity from eluate flowing through a line in system 10, detector 34 may be calibrated by flowing the isotope having the known activity past the detector (e.g., a the same rate as eluate will flow past the detector in operation).
- a controller associated with the calibration process may identify a region of interest encompassing the 776 keV peak in a gamma ray spectrum generated from the sample.
- the region of interest may be the same region of interest subsequently used to determine the activity associated with the 776 keV line of rubidium-82 during operation of system 10.
- the controller can determine the net peak integral count for region of interest to determine the amount of activity measured by detector 34 at or around the 776 keV line for the isotope having the known activity.
- the controller can determine an efficiency factor (e.g. a calibration factor) for detector 34 at the 776 keV line (152).
- the controller may divide the detected activity of the isotope at or around the 776 keV line (e.g., the net peak integral measured for the isotope over the 776 keV region of interest) by the known activity at or around the 776 keV line for the isotope.
- the controller can store this efficiency factor in a memory associated with detector 34 (154), which may be referenced during operation of system 10.
- the measured activity may be adjusted using the efficiency factor.
- Controller 36 can divide the net peak integral count measured over the 776 keV line for rubidiuim-82 by the detector's efficiency factor for the 776 keV line. This adjusted activity can then be used in subsequent activity calculations, as described with respect to FIG. 3.
- the example technique further includes positioning a second isotope having a known activity and emitting gamma radiation at or around the 51 1 keV line (e.g., within a range of plus or minus 5 keV) of the spectrum before detector 34 so that the detector detects the emitted radiation (156).
- the isotope is liquid sodium-22, which emits at the 51 1 keV line of the spectrum.
- the isotope may be statically positioned before the detector for a period of time or may be flowed past the detector.
- a controller associated with the calibration process may identify a region of interest encompassing the 51 1 keV peak in a gamma ray spectrum generated from the sample.
- the region of interest may be the same region of interest subsequently used to determine the activity encompassing the 511 keV line of rubidium-82 and the 514 keV line of strontium-85 during operation of system 10.
- the controller can determine the net peak integral count for region of interest to determine the amount of activity measured by detector 34 at the 511 keV line for the isotope having the known activity.
- the controller can determine an efficiency factor (e.g. a calibration factor) for detector 34 at or around the 51 1 keV line (154).
- This efficiency factor may be representative of the efficiency of the detector at region encompassing both the 51 1 keV line and the 514 keV line.
- the controller may divide the detected activity of the isotope at the 51 1 keV line (e.g., the net peak integral measured for the isotope over the 511 keV and 514 keV region of interest) by the known activity at or around the 51 1 keV line for the isotope.
- the controller can store this efficiency factor in a memory associated with detector 34 (158), which may be referenced during operation of system 10.
- the measured activity may be adjusted using the efficiency factor.
- Controller 36 can divide the net peak integral count encompassing the 51 1-514 keV lines by the detector's efficiency factor for the 511 keV line. This adjusted activity can then be used in subsequent activity calculations, as described with respect to FIG. 3.
- the calibration technique on detector 34 can be repeated using additional isotopes having known activities and emitting gamma radiation at the energies that will subsequently be measured using the detector during operation (162).
- detector 34 may be calibrated for the 32 keV line used to measure the activity of cesium- 131 in system 10.
- an isotope having a known activity and emitting gamma radiation at or around the 32 keV line of the spectrum can be positioned before (e.g., flowed passed) detector 34 so that the detector detects the emitted radiation.
- Liquid cesium- 137 has a multiplet at 32 keV and may be used as a calibration isotope.
- a controller associated with the calibration process may identify a region of interest encompassing the 32 keV peak in a gamma ray spectrum generated from the sample.
- the region of interest may be the same region of interest subsequently used to determine the activity of the 32 keV line for cesium-131.
- the controller can determine the net peak integral count for region of interest and, upon comparing the measured net peak integral activity with the known activity, determine an efficiency factor for the 32 keV for the detector. This efficiency factor may be stored in a memory associated with controller 36 and referenced during operation of system 10.
- system 10 can store and/or use radioisotope activity information monitored by and/or determined by controller 36 via detector 34 in a number of different ways.
- controller 36 stores activity data generated during operation of radioisotope generator 16 in a memory associated with the system.
- the memory may be at the same physical location generator or may be at a physically remote location.
- the data may allow the operational performance and integrity of system 10, including radioisotope generator 16, to be monitored and evaluated.
- controller 36 may actively control system 10 based on radioactivity data determined via detector 34.
- controller 36 may compare a measured activity for a particular isotope or combination of isotopes in eluate generated by system 10 to one or more thresholds stored in memory.
- the threshold(s) may relate to a maximum amount of isotope that can be dosed at any one time. Examples of such thresholds may include a maximum strontium-82 dose of 0.01 ⁇ per mCi of rubidium-82 being dosed and/or a maximum strontium-85 dose of 0.1 ⁇ per mCi of rubidium-82 being dosed.
- the thresholds may include a maximum strontium-82 dose of 0.02 ⁇ per mCi of rubidium-82 being dosed and/or a maximum strontium-85 dose of 0.2 ⁇ per mCi of rubidium-82 being dosed.
- the threshold(s) may also relate to a maximum amount of isotope that can be dosed over a given period of time, such as a patient dosing procedure.
- An example of such a threshold may be a dose of rubidium-82 of 2220 MBq (60 mCi) over the course of a dosing procedure for a single patient.
- Controller 36 may take a variety of actions when a threshold is exceeded. As one example, controller 36 may initiate a user alert (e.g., a visual, textual, audible user alert). As another example, controller 36 may shut down eluant pump 14 so as to cease generating eluate. As yet another example, controller 36 may control second diverter valve 30 to divert elute from patient line 28 to waste line 32.
- a user alert e.g., a visual, textual, audible user alert
- controller 36 may shut down eluant pump 14 so as to cease generating eluate.
- controller 36 may control second diverter valve 30 to divert elute from patient line 28 to waste line 32.
- a periodic constancy check may be performed on system 10, including detector 34, by positioning a calibration source in close proximity to the detector.
- a source of cesium-137 emitting at the 661.7 keV line may be positioned adjacent to detector 34.
- system 10 will measure activity emitted from the isotope and, upon referencing the half-life of the isotope stored in a memory associated with the system, determine if the system is calibrated and functioning properly.
- a periodic (e.g., quarterly) linearity check may be performed on system 10, including detector 34, e.g., by eluting a sample of rubidium-82 and holding the sample statically in front of detector 34 as the sample decays over at least one order of magnitude of activity (e.g., several half-lives).
- System 10 can determine the linearity of the activity measurements made by detector 34 over the decay process, e.g., to identify if the system is functioning properly.
- radioisotope generator 16 can be configured with a variety of different parent radioisotopes to produce daughter decay products besides rubidium-82 for injection into a patent.
- parent- daughter radioisotope pairs different system arrangements and techniques can be used to resolve gamma ray emissions from different isotopes and/or determine the activities for each of a plurality of radioisotopes in a sample under analysis.
- FIG. 5 is a block diagram illustrating another example radioisotope generator system 200 in which different radioisotopes may be detected and quantified using systems and methods in accordance with the disclosure.
- radioisotope generator system 200 includes previously-described eluant reservoir 12, eluant pump 14, and radioisotope generator 16.
- Eluant pump 14 receives eluant from eluant reservoir 12, pressurizes the eluant, and discharges pressurized eluant into radioisotope generator 16 via eluant line 20.
- Radioisotope generator system 200 also includes a radioisotope accumulator structure 202 positioned downstream from radioisotope generator 16. Radioisotope accumulator structure 202 receives eluate from radioisotope generator 16 via elute line 204. Eluate flows over and/or through radioisotope accumulator structure 202 and is discharged for downstream processing or patent injection via line 206.
- radioisotope generator system 200 includes diverter valve 22 controlling the flow of eluant to one of radioisotope generator 16 and accumulator structure 202. Eluant flowing through radioisotope generator bypass line 26 bypasses radioisotope generator 16 and can flow directly into accumulator structure 202.
- radioisotope generator 16 can generate radioisotopes via elution, as discussed above.
- Radioisotope generator 16 contains a parent radioisotope bound on a support material, such as a columnar-shaped support material through with eluant flows during operation.
- the parent radioisotope may bind more strongly to the support material than daughter decay product produced via radioactive decay of the radioisotope.
- the eluant may release daughter decay product so as to generate eluate containing the daughter decay product.
- radioisotope generator system 200 also includes a radiation detector 34, as further described with respect to FIG. 1.
- Detector 34 can be a gamma ray detector that detects gamma rays emanating from eluate generated by radioisotope generator 16.
- Detector 34 can be implemented using any of the detectors discussed above with respect to FIG. 1.
- controller 36 can receive data generated by detector 34 indicative of the amount and type (e.g., spectral distribution) of gamma ray radiation detected by detector 34 and determine therefrom an activity of various radioisotopes present in the eluate produced by radioisotope generator 16.
- radioisotopes that may be desirably identified and/or quantified in eluate generated by radioisotope generator 16 is the parent radioisotope contained within the generator.
- the parent radioisotope within radioisotope generator 16 is intended to remain bound to the support material contained in the generator during elution, releasing only daughter radioisotope into the eluant. This is because the parent radioisotope has a longer half-life than the corresponding daughter radioisotope and, if injected into a patient, will provide a source of radioactivity that persists in the patient for longer than the daughter radioactivity.
- radioisotope generator system 200 includes accumulator structure 202 to help detect and quantify any parent radioisotope present in eluate received from radioisotope generator 16.
- Accumulator structure 202 may be a structure (e.g., material) that preferentially binds any parent radioisotope present in the eluate received via line 204 such that parent radioisotope is attracted out of the eluate and binds to the structure. Conversely, daughter radioisotope present in the eluate may pass over and/or through accumulator structure 202 without substantially binding to the structure, thereby concentrating and separating at least a portion of the parent radioisotope in accumulator structure 202 from the daughter radioisotope.
- a structure e.g., material
- detector 34 can measure gamma radiation emanating from the parent radioisotope (or a daughter decay product thereof), allowing the activity of the parent radioisotope to be quantified.
- Accumulator structure 202 can be fabricated from any materials that a parent radioisotope in a generator system preferentially binds to over a daughter radioisotope.
- accumulator structure 202 can be made from the same or similar materials as the support material in radioisotope generator 16 on which the parent radioisotope is deposited and bound.
- the support material and/or accumulator structure 202 may be stannic oxide, tin oxide, an organic matrix, or yet other material.
- Accumulator structure 202 may provide an enclosed cavity in fluid
- accumulator structure 202 is implemented using a second generator column positioned downstream from radioisotope generator 16.
- the second generator column may be the same as or similar to a generator column in radioisotope generator 16 (but be devoid of parent radioisotope upon the start of system 200, with parent radioisotope accumulating on the second column over time).
- detector 34 may be positioned to detect radiation emitted from the structure.
- detector 34 is illustrated as being positioned to detect radiation emitted from the parent radioisotope captured by accumulator structure 202.
- detector 34 may be positioned in other locations, such as downstream of accumulator structure 202 to detect gamma radiation emitted from liquid passing over or through accumulator structure 202 and picking up accumulated parent radioisotope.
- detector 34 can detect gamma ray emissions emanating from accumulated parent radioisotope (or a decay product thereof) within and/or downstream of accumulator structure 202.
- Controller 36 may receive data generated by detector 34 indicative of the amount and type (e.g., spectral distribution) of gamma ray radiation detected by detector 34. Controller 36 may further process the data to determine an activity of different isotopes in the eluate from which detector 34 detected gamma ray emissions.
- controller 36 can control the system to generate eluate the flows through accumulator structure 202. Controller 36 may instruct eluant pump 14 to pump eluant from eluant reservoir 12 through
- radioisotope generator 16 via eluant line 20.
- eluant line 20 As the pressured eluant flows through radioisotope generator 16, daughter radioisotope generated by radioactive decay of parent radioisotope bound on a support material in the generator can leave the support material and enter the eluant, producing the eluate.
- the eluate discharges from radioisotope generator 16 via line 206 and flows through accumulator structure 202, subsequently discharging from accumulator structure 202 via line 206.
- eluant pump 14 may pump eluant through radioisotope generator 16 and accumulator structure 202 at a rate ranging from 25 ml/min to 75 ml/min (e.g., 50 min/min), resulting in an eluate flow rate ranging from 25 ml/min to 75 ml/min.
- controller 36 may receive gamma ray spectroscopy data from detector 34 indicative of the gamma radiation (e.g., magnitude, distribution) detected by detector 34 from the eluate.
- Detector 34 may detect, and controller 36 may receive, the gamma radiation as the eluate flows through accumulator structure 202.
- Detector 34 may continuously detect gamma rays emitted by eluate flowing through the structure during elution.
- controller 36 may determine an amount of activity associated with one or more radioisotopes (e.g., a daughter radioisotope) in the eluate. To determine the amount of activity associated with a radioisotope of interest, controller 36 may identify a region of interest encompassing an energy line at which the radioisotope of interest emits and integrate the area under the peak. The region of interest may be a region defined between two different energy lines that includes the peak of interest and bounds the region under which the peak area is integrated to determine corresponding activity.
- controller 36 can control system 200 to cease elution.
- controller 36 can control diverter valve 22 to redirect the flow of eluant from radioisotope generator 16 to accumulator structure 202 via bypass line 26.
- Eluant flowing directly to accumulator structure 202 via bypass line 26 can push residual eluate (and daughter radioisotope) through accumulator structure 202.
- controller 36 can control gamma detector 34 to measure the amount of gamma radiation emanating from accumulator structure 202 and/or eluant in or flowing through the structure. Since daughter radioisotope present in the eluate has been flushed through accumulator structure 202, substantially any radioactivity measured by detector 34 may be attributed to parent radioisotope captured on the accumulator structure (or a decay product thereof), thereby providing an indication of the amount of parent radioisotope present in the eluate.
- controller 36 may receive gamma ray spectroscopy data from detector 34 indicative of the gamma radiation (e.g., magnitude, distribution) detected by detector 34 from accumulator structure 202 and/or eluant in or flowing through the structure. Upon receiving gamma ray spectroscopy data from detector 34, controller 36 may determine an amount of activity associated with one or more radioisotopes (e.g., a parent radioisotope) emitting radiation. To determine the amount of activity associated with a radioisotope of interest, controller 36 may identify a region of interest
- the region of interest may be a region defined between two different energy lines that includes the peak of interest and bounds the region under which the peak area is integrated to determine corresponding activity.
- controller 36 may adjust the measured activity to determine the amount of parent radioisotope present in the eluate generated by radioisotope generator 16.
- the amount of parent radioisotope captured on or in accumulator structure 202 that emits gamma radiation can vary over the life of radioisotope generator system 200. Initially, accumulator structure 202 may contain no parent radioisotope such that substantially any gamma radiation measured from accumulator structure 202 after an initial elution may be attributed to parent radioisotope released from radioisotope generator 16.
- parent radioisotope can accumulate on accumulator structure 202 such that during subsequent elutions, a portion of the gamma radiation emitted by parent radioisotope captured on accumulator structure 202 can be attributed to parent radioisotope captured during prior elutions and another portion can be attributed to parent radioisotope captured during a current run in which the activity of parent radioisotope present in the eluate is desired to be quantified. For this reason, controller 36 may decrease the measured activity of the parent radioisotope by an amount proportional to the percentage of the parent radioisotope attributable to prior elution runs as opposed to the current elution run.
- Controller 36 may also increase the measured activity of the parent radioisotope to account for the capture efficiency of accumulator structure 202. While accumulator structure 202 can preferentially bind parent radioisotope to the structure, the structure may not be capable of capturing all parent radioisotope present in the eluate generated by radioisotope generator 16. Accordingly, the amount of parent radioisotope determined to be in the eluate sample based on the measured gamma radiation (as optionally adjusted to account for any legacy parent radioisotope from prior elution runs) can be upwardly adjusted to reflect the capture efficiency of accumulator structure 202. The resulting value can be established as the measured activity of parent radioisotope in the eluate being analyzed.
- FIG. 6 is a flow diagram of an example technique that may be used to detect and quantify a parent radioisotope, a daughter radioisotope, and/or any other desired radioisotopes in a system according to the example of FIG. 5.
- the technique of FIG. 6 may be used by radioisotope generator system 200 of FIG. 1 to determine an activity of germanium-68 and/or gallium-68.
- radioisotope generator 16 may be a 68 Ge/ 68 Ga generator that produces 68 Ga from radioactive decay of 68 Ge.
- controller 36 controls eluant pump 14 to pump pressurized eluant (e.g., HC1 solution) through radioisotope generator 16, producing an eluate containing gallium-68 and germanium-68 that discharges from line 204 (300).
- eluate flows over and/or through accumulator structure 202, causing a portion of the germanium-68 to bind to the accumulator structure.
- accumulator structure 202 is a chemistry column (e.g., having a shape and/or construction that is the same as the generator column in radioisotope generator 16 except that the generator column is loaded with germanium whereas the chemistry column is devoid of germanium upon start up).
- the chemistry column may function to remove germanium-68 from the eluate and/or neutralize the pH of the eluate for injection.
- accumulation structure 202 may be an ion exchange member that functions to remove germanium-68 from the eluate.
- the chemistry column may be positioned upstream from or form part of a chemistry vial or chemistry cassette containing reagents for reacting with the eluate.
- the amount of germanium-68 binding to the chemistry column may be greater than the amount of gallium-68 binding to the column.
- controller 36 receives gamma ray spectroscopy data from detector 34 indicative of the gamma radiation (e.g., magnitude, distribution) detected by detector 34 from the eluate flowing through and/or over accumulator structure 202 (302).
- gamma radiation e.g., magnitude, distribution
- Detector 34 may continuously or periodically detect gamma rays emitted by eluate flowing through accumulator structure 202. As the concentration of radioisotopes in the eluate change, detector 34 may detect changing gamma radiation from the eluate.
- controller 36 may determine an amount of activity associated with gallium-68 (304).
- Gallium-68 emits at the 511 keV line of the spectrum.
- germanium-68 does not emit within the gamma spectrum. Accordingly, substantially any or all gamma radiation measured by gamma detector 34 from the eluate may be attributed to gallium-68.
- controller 36 may identify a region of interest encompassing the 51 1 keV peak and integrate the area under the peak. The region of interest may be a region defined between two different energy lines that includes the peak of interest and bounds the region under which the peak area is integrated to determine corresponding activity. Controller 36 may store this determined activity as the activity of gallum-68.
- the technique of FIG. 6 includes terminating elution and optionally flushing accumulator structure 202 (306).
- controller 36 controls diverter valve 22 to redirect the flow of eluant from radioisotope generator 16 to accumulator structure 202 via bypass line 26.
- Eluant flowing directly to accumulator structure 202 via bypass line 26 can push residual eluate (and gallium-68 contained therein) through accumulator structure 202. This can reduce residual gamma ray emissions emitted from gallium-68 radionuclides produced inside of radioisotope generator 16 and carried to accumulator structure 202 via flowing eluant.
- the technique of FIG. 6 can be performed by terminating elution (e.g., ceasing operation of eluant pump 14) without flushing accumulator structure 202.
- controller 36 in the technique of FIG. 6 again receives gamma ray spectroscopy data from detector 34 indicative of the gamma radiation (e.g., magnitude, distribution) detected by detector 34 from radioisotopes present in accumulator structure 202 (308). While germanium-68 does not itself emit in the gamma spectrum, the germanium decays to gallium-68, which emits at the 51 1 keV line as discussed above.
- gamma radiation e.g., magnitude, distribution
- gallium-68 Since the flow of gallium-68 from radioisotope generator 16 has been terminated (and accumulator structure 202 optionally flushed to remove residual gallium-68), gamma radiation emitted by gallium-68 and detected by detector 34 may be attributed as the decay product of germanium-68 captured by accumulator structure 202.
- controller 36 may determine an amount of activity associated with germanium-68 by measuring the amount of activity attributable to its decay product gallium-68 (310). To determine the amount of activity associated with germanium-68, controller 36 may identify a region of interest encompassing the 511 keV peak and integrate the area under the peak. Controller 36 can determine from this integration the amount of activity associated with gallium-68 decayed from germanium-68 captured from the eluate by accumulator structure 202.
- controller 36 can convert the measured activity of gallium-68 (310) into a corresponding germanium-68 activity. For example, with reference to data stored in memory, controller 36 can account for the decay rate of germanium-68 to gallium-68, the efficiency of accumulator structure 202 at capturing and binding germanium-68 out of the eluate, and the presence of any gallium-68 attributable to germanium-68 captured during prior elution runs (as adjusted for the decay of such germanium) to convert the measured activity of gallium-68 to an activity of germanium- 68 in the eluate produced from radioisotope generator 16.
- system 200 can store and/or use radioisotope activity information in a number of different ways.
- controller 36 stores activity data generated during operation of radioisotope generator 16 in a memory associated with the system.
- the memory may be at the same physical location generator or may be at a physically remote location.
- the data may allow the operational performance and integrity of system 200, including radioisotope generator 16, to be monitored and evaluated.
- controller 36 may actively control system 200 based on radioactivity data determined via detector 34.
- controller 36 may compare a measured activity for a particular isotope (e.g., 68 Ge, 68 Ga) or combination of isotopes in eluate generated by system 200 to one or more thresholds stored in memory.
- the threshold(s) may provide a maximum amount of isotope that can be dosed at any one time.
- Controller 36 may take a variety of actions when a threshold is exceeded. As one example, controller 36 may initiate a user alert. As another example, controller 36 may control a downstream process from radioisotope generator 16 to prevent eluate generated therefrom from being injected into a patient.
- FIG. 6 While the example technique of FIG. 6 has been described with respect to a germanium-gallium radioisotope generator, it should be appreciated the configuration of system 200 in FIG. 5 and the technique of FIG. 6 is not limited such an example generator. Such systems and techniques can be implemented using any desired radioisotope generator, including those described herein.
- radioisotope generator 16 can be calibrated using a calibration source emitting at or around the 51 1 keV line, as discussed above with respect to FIG. 4.
- processors including one or more microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components.
- DSPs digital signal processors
- ASICs application specific integrated circuits
- FPGAs field programmable gate arrays
- processors may generally refer to any of the foregoing logic circuitry, alone or in combination with other logic circuitry, or any other equivalent circuitry.
- a control unit comprising hardware may also perform one or more of the techniques of this disclosure.
- Such hardware, software, and firmware may be implemented within the same device or within separate devices to support the various operations and functions described in this disclosure.
- any of the described units, modules or components may be implemented together or separately as discrete but interoperable logic devices. Depiction of different features as modules or units is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be realized by separate hardware or software components. Rather, functionality associated with one or more modules or units may be performed by separate hardware or software components, or integrated within common or separate hardware or software components.
- the techniques described in this disclosure may also be embodied or encoded in a non-transitory computer-readable medium, such as a computer-readable storage medium, containing instructions. Instructions embedded or encoded in a computer- readable storage medium may cause a programmable processor, or other processor, to perform the method, e.g., when the instructions are executed.
- Non-transitory computer readable storage media may include volatile and/or non- volatile memory forms including, e.g., random access memory (RAM), read only memory (ROM), programmable read only memory (PROM), erasable programmable read only memory (EPROM), electronically erasable programmable read only memory (EEPROM), flash memory, a hard disk, a CD- ROM, a floppy disk, a cassette, magnetic media, optical media, or other computer readable media.
- RAM random access memory
- ROM read only memory
- PROM programmable read only memory
- EPROM erasable programmable read only memory
- EEPROM electronically erasable programmable read only memory
- flash memory a hard disk, a CD- ROM, a floppy disk, a cassette, magnetic media, optical media, or other computer readable media.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- High Energy & Nuclear Physics (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Measurement Of Radiation (AREA)
- Nuclear Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2016140051A RU2685087C2 (en) | 2014-03-13 | 2015-03-13 | Detection of nuclear isotopes in real time |
AU2015229189A AU2015229189B2 (en) | 2014-03-13 | 2015-03-13 | Real time nuclear isotope detection |
CA2940697A CA2940697C (en) | 2014-03-13 | 2015-03-13 | Real time nuclear isotope detection |
KR1020167025218A KR20160133451A (en) | 2014-03-13 | 2015-03-13 | Real time nuclear isotope detection |
SG11201607096PA SG11201607096PA (en) | 2014-03-13 | 2015-03-13 | Real time nuclear isotope detection |
CN201580013346.8A CN106104303B (en) | 2014-03-13 | 2015-03-13 | Real-time core isotope detection |
EP15713107.9A EP3117240A1 (en) | 2014-03-13 | 2015-03-13 | Real time nuclear isotope detection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461952270P | 2014-03-13 | 2014-03-13 | |
US61/952,270 | 2014-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015138910A1 true WO2015138910A1 (en) | 2015-09-17 |
Family
ID=52774596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/020461 WO2015138910A1 (en) | 2014-03-13 | 2015-03-13 | Real time nuclear isotope detection |
Country Status (9)
Country | Link |
---|---|
US (2) | US9766351B2 (en) |
EP (1) | EP3117240A1 (en) |
KR (1) | KR20160133451A (en) |
CN (1) | CN106104303B (en) |
AU (1) | AU2015229189B2 (en) |
CA (1) | CA2940697C (en) |
RU (1) | RU2685087C2 (en) |
SG (1) | SG11201607096PA (en) |
WO (1) | WO2015138910A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8317674B2 (en) | 2008-06-11 | 2012-11-27 | Bracco Diagnostics Inc. | Shielding assemblies for infusion systems |
CN104784770B (en) | 2008-06-11 | 2019-06-11 | 布拉科诊断公司 | The infusion system safeguarded and/or operated including area of computer aided |
FR2995536B1 (en) * | 2012-09-17 | 2014-09-26 | Lemer Prot Anti X Par Abreviation Soc Lemer Pax | MEDICAL UNIT FOR THE INJECTION OF RUBIDIUM 82 TO A PATIENT |
CN117854793A (en) | 2016-09-20 | 2024-04-09 | 布拉科诊断公司 | Radioisotope delivery system with multiple detectors for detecting gamma and beta emissions |
EP3571528A1 (en) * | 2017-01-20 | 2019-11-27 | Curium US LLC | Systems and methods for assaying an eluate of a radionuclide generator |
EP3658034A1 (en) * | 2017-07-25 | 2020-06-03 | Bayer Aktiengesellschaft | Apparatus for radiopharmaceutical quantification of a body part |
US10245002B2 (en) * | 2017-08-01 | 2019-04-02 | Siemens Medical Solutions Usa, Inc. | Isotope specific calibration of a dose calibrator for quantitative functional imaging |
FR3075976B1 (en) * | 2017-12-21 | 2020-01-10 | Areva Nc | METHOD FOR DETERMINING A QUANTITY OF A RADIOISOTOPE |
WO2019191386A1 (en) | 2018-03-28 | 2019-10-03 | Bracco Diagnostics Inc. | Early detection of radioisotope generator end life |
SG11202009321SA (en) | 2018-03-28 | 2020-10-29 | Bracco Diagnostics Inc | Systems and techniques for calibrating radioisotope delivery systems with a gamma detector |
US11791060B2 (en) | 2019-03-29 | 2023-10-17 | Jubilant Draximage Inc. | Elution protocols and dosages for radiopharmaceutical elution system |
EP4111340A4 (en) * | 2020-02-28 | 2024-03-27 | Jubilant Pharma Holdings Inc. | Radiopharmaceutical infusion system |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0160303A2 (en) * | 1983-02-28 | 1985-11-06 | E.R. Squibb & Sons, Inc. | Strontium-rubidium infusion system |
US4859431A (en) * | 1986-11-10 | 1989-08-22 | The Curators Of The University Of Missouri | Rhenium generator system and its preparation and use |
WO2007096119A2 (en) * | 2006-02-21 | 2007-08-30 | Actinium Pharmaceuticals, Inc. | Method for purification of 225ac from irradiated 226ra-targets |
WO2009152320A2 (en) * | 2008-06-11 | 2009-12-17 | Bracco Diagnostics Inc. | Shielding assemblies for infusion systems |
EP2332593A2 (en) * | 2009-12-14 | 2011-06-15 | Medrad, Inc. | A device and method for determining activity of radiopharmaceutical material |
WO2013082699A1 (en) * | 2011-12-08 | 2013-06-13 | Nordion (Canada) Inc. | Method of pre-treating an adsorbent for a chromatographic separation |
Family Cites Families (129)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3535085A (en) | 1967-08-07 | 1970-10-20 | Mallinckrodt Chemical Works | Closed system generation and containerization of radioisotopes |
US3483867A (en) | 1968-06-13 | 1969-12-16 | Meyer Markovitz | Artificial glomerulus and a method for treating blood |
US3565376A (en) | 1969-08-04 | 1971-02-23 | Gen Motors Corp | Tubing support |
US3710118A (en) | 1970-05-25 | 1973-01-09 | Mallinckrodt Chemical Works | Radioisotope generator |
US3714429A (en) | 1970-09-28 | 1973-01-30 | Afee J Mc | Tomographic radioisotopic imaging with a scintillation camera |
US3774036A (en) | 1972-02-23 | 1973-11-20 | Searle & Co | Generation of a supply of radionuclide |
US3847138A (en) | 1973-03-14 | 1974-11-12 | S Gollub | Method and system for controlled automated administration of drugs to patients |
JPS5341756Y2 (en) | 1974-10-31 | 1978-10-07 | ||
US3997784A (en) | 1975-06-16 | 1976-12-14 | Union Carbide Corp | Automatic apparatus for dispensing radiodiagnostic agents and method therefor |
US4096859A (en) | 1977-04-04 | 1978-06-27 | Agarwal Mahesh C | Apparatus for peritoneal dialysis |
US4160910A (en) | 1977-06-20 | 1979-07-10 | Union Carbide Corporation | Rechargeable 99MO/99MTC generator system |
US4212303A (en) | 1978-07-17 | 1980-07-15 | Hollister Incorporated | Umbilical cord clamp |
NL190345C (en) | 1978-10-20 | 1994-01-17 | Mallinckrodt Diagnostica Bv | SCREEN DEVICE FOR A RADIO ISOTOPE GENERATOR. |
DE3172813D1 (en) | 1980-05-20 | 1985-12-12 | Haemonetics Corp | Suction liquid collection assembly and flexible liquid collection bag suitable for use therein |
US4336036A (en) | 1981-01-08 | 1982-06-22 | Amf Incorporated | Filter and method of making same |
EP0102121A1 (en) | 1982-08-26 | 1984-03-07 | Mallinckrodt Diagnostica (Holland) B.V. | Shielding device for a reservoir comprising a radioactive material |
US4585009A (en) | 1983-02-28 | 1986-04-29 | E. R. Squibb & Sons, Inc. | Strontium-rubidium infusion pump with in-line dosimetry |
AT379253B (en) | 1983-08-17 | 1985-12-10 | Bender & Co Gmbh | METHOD AND DEVICE FOR ELUING AND DOSING A RADIOACTIVE NUCLEID |
US4623102A (en) | 1983-12-14 | 1986-11-18 | Apple Adhesives, Inc. | Article clamp |
SE441261B (en) | 1984-03-26 | 1985-09-23 | Jan Ingemar Neslund | PASKLEMMA |
US4679142A (en) | 1984-07-02 | 1987-07-07 | E.I. Du Pont De Nemours And Company | Radioactive material billing system and method |
US4674403A (en) | 1985-08-27 | 1987-06-23 | New Holland Inc. | Semi-automatic baler control and indicator system |
US4755679A (en) | 1986-06-19 | 1988-07-05 | Wong Wai Hoi | Method and apparatus for maximizing counts of a PET camera |
US4853546A (en) | 1986-09-16 | 1989-08-01 | Ube Industries, Ltd. | Automatic radioisotope filling apparatus |
US4769008A (en) | 1986-11-26 | 1988-09-06 | Infusion Systems Corporation | Pressurized fluid dispenser |
US4759345A (en) | 1987-02-09 | 1988-07-26 | Mistry Vitthalbhai D | Radiation shielded seed loader for hand implanter hypodermic needles apparatus and method |
JPH0622015B2 (en) | 1987-11-30 | 1994-03-23 | インターナシヨナル・ビジネス・マシーンズ・コーポレーシヨン | Data processing system control method |
US5258906A (en) | 1988-07-13 | 1993-11-02 | Vital Heart Systems, Inc. | System for remotely authorizing operation of a device and for automatically generating an invoice based on device usage |
US5039863A (en) | 1988-11-15 | 1991-08-13 | Ube Industries, Ltd. | Automatic radioisotope filling apparatus |
WO1991000846A1 (en) | 1989-07-12 | 1991-01-24 | Mallinckrodt Medical, Inc. | Method for preparing radiodiagnostic gaseous radionuclide and apparatus |
US4994056A (en) | 1989-11-09 | 1991-02-19 | Ikeda Daniel P | Unit dose medicament storing and mixing system |
ATE226282T1 (en) | 1992-06-09 | 2002-11-15 | Baxter Int | PROGRAMMABLE INFUSION PUMP WITH INTERCHANGEABLE TUBING |
US5274239A (en) | 1992-07-23 | 1993-12-28 | Sunol Technologies, Inc. | Shielded dose calibration apparatus |
GB9225014D0 (en) | 1992-11-30 | 1993-01-20 | Univ Hospital London Dev Corp | Pulse injector for quantitative angiographic blood-flow measurements |
US5590648A (en) | 1992-11-30 | 1997-01-07 | Tremont Medical | Personal health care system |
US5475232A (en) | 1992-12-22 | 1995-12-12 | Syncor International Corp. | Method for elution of a radioisotope according to an elution run schedule |
RU2131273C1 (en) | 1993-04-13 | 1999-06-10 | Сайенс Инкорпорейтед | Liquid delivery device |
EP0650739B1 (en) | 1993-10-28 | 2003-02-26 | Medrad, Inc. | Total system for contrast delivery |
DE69526613T2 (en) | 1994-07-12 | 2002-08-29 | Medrad, Inc. | Information path control loop for a system that delivers medical fluids |
US5840026A (en) | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
DE69533965D1 (en) | 1994-11-15 | 2005-03-03 | Johnson Medical Dev Pte Ltd | FASTENING DEVICE FOR HOSPITAL APPARATUS |
US5702115A (en) | 1995-01-10 | 1997-12-30 | Pool; L. Frank | Patient care utility cart |
US5827429A (en) | 1996-01-18 | 1998-10-27 | Filtertek Inc. | Intravenous filter device |
US5765842A (en) | 1996-07-24 | 1998-06-16 | Phaneuf; Simon | Medical emergency treatment cart |
EP0919249B1 (en) | 1997-11-20 | 2005-01-12 | Nipro Corporation | A blood filter set and a method of recovering blood components by use of the same |
US6267717B1 (en) | 1998-03-31 | 2001-07-31 | Advanced Research & Technology Institute | Apparatus and method for treating a body structure with radiation |
EP1075654A4 (en) | 1998-04-27 | 2003-06-04 | Gen Hospital Corp | Radiation handling system and set |
DE29811529U1 (en) | 1998-06-27 | 1999-11-25 | B. Braun Melsungen Ag, 34212 Melsungen | Filters for medical liquids |
US6220554B1 (en) | 1998-06-30 | 2001-04-24 | Lucent Technologies, Inc. | Wire clip |
US6454460B1 (en) | 1998-09-08 | 2002-09-24 | Naganathasastrigal Ramanathan | System and method for evaluating and calibrating a radiation generator |
US7612999B2 (en) | 1998-09-18 | 2009-11-03 | Flo Healthcare Solutions, Llc | Mobile clinical workstation |
US6157036A (en) | 1998-12-02 | 2000-12-05 | Cedars-Sinai Medical Center | System and method for automatically eluting and concentrating a radioisotope |
DE19900937A1 (en) | 1999-01-13 | 2000-07-20 | Ulrich Gmbh & Co Kg | Injector for the application of liquids with a pressure measuring system |
US6450936B1 (en) | 1999-04-30 | 2002-09-17 | Mallinckrodt Inc. | Manifold device for manipulation of radioactive fluid |
JP2000350783A (en) | 1999-06-14 | 2000-12-19 | Sumitomo Heavy Ind Ltd | Injection method and apparatus of radioactive liquid |
US7169352B1 (en) | 1999-12-22 | 2007-01-30 | Gambro, Inc. | Extracorporeal blood processing methods and apparatus |
US6626862B1 (en) | 2000-04-04 | 2003-09-30 | Acist Medical Systems, Inc. | Fluid management and component detection system |
WO2002026288A2 (en) | 2000-09-27 | 2002-04-04 | Cobe Cardiovascular, Inc. | Disposable cartridge for a blood perfusion system |
JP4659962B2 (en) * | 2000-10-04 | 2011-03-30 | 株式会社東芝 | Nuclear medicine diagnostic equipment |
IL156245A0 (en) | 2000-12-22 | 2004-01-04 | Dca Design Int Ltd | Drive mechanism for an injection device |
US20020129471A1 (en) | 2001-03-14 | 2002-09-19 | Chin-Yang Wang | Wire lock |
AU2002309987A1 (en) | 2001-05-25 | 2002-12-09 | Hill-Rom Services, Inc. | Modular patient room |
US6767319B2 (en) | 2001-06-29 | 2004-07-27 | Medrad, Inc. | Delivery methods, systems and components for use with hazardous pharmaceutical substances |
US6908598B2 (en) | 2001-08-02 | 2005-06-21 | Lynntech, Inc. | Rubidlum-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets |
US7476377B2 (en) | 2001-08-02 | 2009-01-13 | Lynntech, Inc. | Rubidium-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets |
US7630907B2 (en) | 2001-10-30 | 2009-12-08 | Biodose, Llc | Algorithm and program for the handling and administration of radioactive pharmaceuticals |
US6639237B2 (en) | 2001-11-02 | 2003-10-28 | Mentor Corporation | Brachytherapy medical devices |
GB2386743B (en) | 2002-04-11 | 2004-02-11 | Amersham Plc | Radioisotope generator |
ITMI20022473A1 (en) | 2002-11-21 | 2004-05-22 | Gvs Spa | INFUSION FILTER OPERATING EFFECTIVELY IN VARIOUS SPACE POSITIONS. |
WO2004059661A1 (en) | 2002-12-30 | 2004-07-15 | Lynntech, Inc. | Rubidium-82 generator based on sodium nonatitanate support, and separation methods for the recovery of the recovery of strontium-82 from irradiated targets |
CN2677923Y (en) * | 2004-03-05 | 2005-02-09 | 清华大学 | Gamma radiation image nondestructive detector for chest or luggage |
CN1217185C (en) * | 2003-06-27 | 2005-08-31 | 清华大学 | Gamma radiation imaging nondestructive inspection system for bag, box or baggage |
AU2003903404A0 (en) | 2003-07-02 | 2003-07-17 | Iphase Technologies Pty. Limited | Automated radioactive dose dispenser |
US7367358B2 (en) | 2005-02-02 | 2008-05-06 | Universal Infusion Technology, Llc | Medical fluid delivery system and method relating to the same |
US7286867B2 (en) | 2003-10-16 | 2007-10-23 | Brookhaven Science Associates, Llc | Combined PET/MRI scanner |
US7256888B2 (en) | 2003-11-07 | 2007-08-14 | Cardial Health 303, Inc. | Fluid verification system and method for infusions |
KR100878282B1 (en) | 2003-11-26 | 2009-01-12 | 어시스트 메디칼 시스템즈, 인크. | Device and method for dispensing media as part of a medical procedure |
WO2005083393A1 (en) | 2004-01-27 | 2005-09-09 | Arcana International, Inc. | System for the control, verification and recording of the performance of a radioisotope generator’s operations |
KR100811667B1 (en) | 2004-02-11 | 2008-03-11 | 이-지-이엠, 인코포레이티드 | Method system and apparatus for operating a medical injector and diagnostic imaging device |
US20050187515A1 (en) | 2004-02-19 | 2005-08-25 | Advanced Neuromodulation Systems, Inc. | Reduced size programmable drug pump |
US7734331B2 (en) | 2004-03-02 | 2010-06-08 | General Electric Company | Systems, methods and apparatus for preparation, delivery and monitoring of radioisotopes in positron emission tomography |
EP1755704B1 (en) | 2004-05-27 | 2008-02-27 | E-Z-EM, Inc. | System, method, and computer program product for handling, mixing, dispensing, and injecting radiopharmaceutical agents |
US7163031B2 (en) | 2004-06-15 | 2007-01-16 | Mallinckrodt Inc. | Automated dispensing system and associated method of use |
EP1616587A1 (en) | 2004-07-16 | 2006-01-18 | Universität Zürich | Method and device for accurate dispensing of radioactivity |
CA2784171C (en) | 2004-08-30 | 2018-11-20 | Bracco Diagnostics Inc. | Improved containers for pharmaceuticals, particularly for use in radioisotope generators |
EP1827505A4 (en) * | 2004-11-09 | 2017-07-12 | Biosensors International Group, Ltd. | Radioimaging |
DK1835959T3 (en) | 2004-11-24 | 2013-03-25 | Medrad Inc | Fluid delivery devices, systems and methods |
WO2006074473A2 (en) | 2005-01-10 | 2006-07-13 | Livengood Engineering, Inc. | Modular patient support system |
US20060211989A1 (en) | 2005-03-04 | 2006-09-21 | Rhinehart Edward J | Fluid delivery systems, devices and methods for delivery of fluids |
DE102005015070B4 (en) | 2005-04-01 | 2017-02-02 | Siemens Healthcare Gmbh | Combined positron emission tomography and magnetic resonance tomography device |
ES2352980T3 (en) | 2005-04-06 | 2011-02-24 | Mallinckrodt, Inc. | SYSTEMS AND METHODS FOR MANAGING INFORMATION RELATED TO MEDICAL FLUIDS AND RECIPIENTS FOR THEMSELVES. |
RU2288755C1 (en) | 2005-04-25 | 2006-12-10 | Виктор Васильевич Щетинин | Device for radionuclide surgery |
JP2006325826A (en) | 2005-05-25 | 2006-12-07 | Universal Giken:Kk | Radiopharmaceuticals sucking device |
CA2610256A1 (en) | 2005-06-01 | 2006-12-07 | Spectrum Dynamics | Unified management of radiopharmaceutical dispensing, administration, and imaging |
DE102005031920B4 (en) | 2005-07-07 | 2007-12-20 | Isotopen Technologien München AG | Apparatus and method for producing a small amount of a radioactive compound |
WO2007016170A1 (en) | 2005-07-27 | 2007-02-08 | Mallinckrodt Inc. | System and method of identifying eluant amounts supplied to a radioisotope generator |
EP1920443A2 (en) | 2005-08-09 | 2008-05-14 | Mallinckrodt, Inc. | Radioisotope generation system having partial elution capability |
JP2009506343A (en) | 2005-08-29 | 2009-02-12 | マリンクロッド・インコーポレイテッド | System and method for eluting a radioisotope into a container located outside a radioisotope generator assembly |
US20070080223A1 (en) | 2005-10-07 | 2007-04-12 | Sherwood Services Ag | Remote monitoring of medical device |
US8071959B2 (en) | 2005-12-21 | 2011-12-06 | Ottawa Heart Institute Research Corp. | Rubidium generator for cardiac perfusion imaging and method of making and maintaining same |
US20070158271A1 (en) | 2006-01-12 | 2007-07-12 | Draxis Health Inc. | Systems and Methods for Radioisotope Generation |
US7700926B2 (en) | 2006-01-12 | 2010-04-20 | Draximage General Partnership | Systems and methods for radioisotope generation |
JP5148066B2 (en) * | 2006-02-08 | 2013-02-20 | 株式会社東芝 | Nuclear medicine equipment |
US7813841B2 (en) | 2006-03-10 | 2010-10-12 | Ottawa Heart Institute Research Corporation | Rubidium elution system control |
US7825372B2 (en) | 2006-04-11 | 2010-11-02 | Radqual, Llc | Simulated dose calibrator source standard for positron emission tomography radionuclides |
EP2041755A2 (en) * | 2006-07-06 | 2009-04-01 | Mallinckrodt Inc. | System and method for controlling elution from a radioisotope generator with electronic pinch valves |
US7586102B2 (en) | 2006-08-14 | 2009-09-08 | Board Of Regents The University Of Texas System | Automated system for formulating radiopharmaceuticals |
WO2008028165A2 (en) | 2006-08-31 | 2008-03-06 | Catholic Healthcare West(D/B/A St. Joseph's Hospital And Medical Center) | Automated blood draw system |
FR2906475B1 (en) | 2006-09-29 | 2009-01-09 | Lemer Prot Anti X Par Abrevati | MEDICAL UNIT FOR THE COLLECTION, CALIBRATION, DILUTION AND / OR INJECTION OF AN INJECTABLE RADIOACTIVE PRODUCT |
PL3270383T3 (en) | 2006-10-06 | 2020-04-30 | Mallinckrodt Nuclear Medicine Llc | Self-aligning radioisotope elution system |
US20080166292A1 (en) | 2007-01-01 | 2008-07-10 | Medrad, Inc. | Pharmaceutical Dosing Method |
EP2139541B1 (en) | 2007-01-01 | 2018-04-11 | Bayer Healthcare LLC | Systems for integrated radiopharmaceutical generation, preparation, transportation, and administration |
US9056164B2 (en) | 2007-01-01 | 2015-06-16 | Bayer Medical Care Inc. | Radiopharmaceutical administration methods, fluid delivery systems and components thereof |
CN201017036Y (en) * | 2007-03-13 | 2008-02-06 | 北京智博高科生物技术有限公司 | Sealed seed source activity differential counting equipment |
US7996068B2 (en) | 2007-03-14 | 2011-08-09 | The Board Of Trustees Of The Leland Stanford Junior University | Surgical method and apparatus for identification of fluorescence |
US7780352B2 (en) | 2007-03-14 | 2010-08-24 | Varian Medical Systems, Inc. | Radiation system and radiation beam quality detector and method |
WO2008140351A1 (en) | 2007-04-09 | 2008-11-20 | Obshchestvo S Ogranichennoy Otvetstvennostiu 'nauchno-Proizvodstvennaya Firma 'pozitom-Pro' | Automated strontium-rubidium infusion system |
US7608831B2 (en) | 2008-03-18 | 2009-10-27 | James F Lamb | Radioactivity dose calibrator |
EP2315883A4 (en) | 2008-06-06 | 2014-07-09 | Bayer Medical Care Inc | Apparatus and methods for delivery of fluid injection boluses to patients and handling harmful fluids |
US8317674B2 (en) | 2008-06-11 | 2012-11-27 | Bracco Diagnostics Inc. | Shielding assemblies for infusion systems |
US8708352B2 (en) | 2008-06-11 | 2014-04-29 | Bracco Diagnostics Inc. | Cabinet structure configurations for infusion systems |
US9597053B2 (en) | 2008-06-11 | 2017-03-21 | Bracco Diagnostics Inc. | Infusion systems including computer-facilitated maintenance and/or operation and methods of use |
US7862534B2 (en) | 2008-06-11 | 2011-01-04 | Bracco Diagnostics Inc. | Infusion circuit subassemblies |
SI2157583T1 (en) | 2008-08-18 | 2011-10-28 | Stichting Jeroen Bosch Ziekenhuis | Strontium-82/rubidium-82 generator, method for producing a rubidium-82 comprising diagnostic agent, said diagnostic agent and its use in medicine |
US8216181B2 (en) | 2008-11-19 | 2012-07-10 | Bracco Diagnostics, Inc. | Apparatus and methods for support of a membrane filter in a medical infusion system |
US8692681B2 (en) | 2009-07-07 | 2014-04-08 | Koninklijke Philips N.V. | Dynamic PET imaging with isotope contamination compensation |
ES2622346T3 (en) | 2009-12-07 | 2017-07-06 | Medi-Physics Inc. | Software product to manage an elution system of multiple generators |
US8442803B2 (en) | 2010-10-21 | 2013-05-14 | Atomic Energy Council - Institute Of Nuclear Energy Research | Method of measuring radiation doses on different directions |
CN103797559B (en) | 2011-06-03 | 2016-09-28 | 珀金埃尔默健康科学股份有限公司 | A kind of equipment for analyzing sample chemical material |
-
2015
- 2015-03-13 CN CN201580013346.8A patent/CN106104303B/en active Active
- 2015-03-13 KR KR1020167025218A patent/KR20160133451A/en not_active IP Right Cessation
- 2015-03-13 AU AU2015229189A patent/AU2015229189B2/en active Active
- 2015-03-13 EP EP15713107.9A patent/EP3117240A1/en not_active Withdrawn
- 2015-03-13 US US14/657,598 patent/US9766351B2/en active Active
- 2015-03-13 WO PCT/US2015/020461 patent/WO2015138910A1/en active Application Filing
- 2015-03-13 CA CA2940697A patent/CA2940697C/en active Active
- 2015-03-13 SG SG11201607096PA patent/SG11201607096PA/en unknown
- 2015-03-13 RU RU2016140051A patent/RU2685087C2/en active
-
2017
- 2017-08-11 US US15/675,344 patent/US10012740B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0160303A2 (en) * | 1983-02-28 | 1985-11-06 | E.R. Squibb & Sons, Inc. | Strontium-rubidium infusion system |
US4859431A (en) * | 1986-11-10 | 1989-08-22 | The Curators Of The University Of Missouri | Rhenium generator system and its preparation and use |
WO2007096119A2 (en) * | 2006-02-21 | 2007-08-30 | Actinium Pharmaceuticals, Inc. | Method for purification of 225ac from irradiated 226ra-targets |
WO2009152320A2 (en) * | 2008-06-11 | 2009-12-17 | Bracco Diagnostics Inc. | Shielding assemblies for infusion systems |
EP2332593A2 (en) * | 2009-12-14 | 2011-06-15 | Medrad, Inc. | A device and method for determining activity of radiopharmaceutical material |
WO2013082699A1 (en) * | 2011-12-08 | 2013-06-13 | Nordion (Canada) Inc. | Method of pre-treating an adsorbent for a chromatographic separation |
Also Published As
Publication number | Publication date |
---|---|
KR20160133451A (en) | 2016-11-22 |
CA2940697A1 (en) | 2015-09-17 |
SG11201607096PA (en) | 2016-09-29 |
RU2016140051A (en) | 2018-04-16 |
RU2685087C2 (en) | 2019-04-16 |
US9766351B2 (en) | 2017-09-19 |
US20170363750A1 (en) | 2017-12-21 |
US10012740B2 (en) | 2018-07-03 |
AU2015229189A1 (en) | 2016-09-08 |
EP3117240A1 (en) | 2017-01-18 |
RU2016140051A3 (en) | 2018-09-12 |
US20150260855A1 (en) | 2015-09-17 |
AU2015229189B2 (en) | 2020-04-09 |
CN106104303A (en) | 2016-11-09 |
CN106104303B (en) | 2019-06-14 |
CA2940697C (en) | 2023-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10012740B2 (en) | Real time nuclear isotope detection | |
AU2022241511B2 (en) | Systems and techniques for generating, infusing, and controlling radioisotope delivery | |
KR20200138273A (en) | Systems and technologies for calibrating radioisotope delivery systems using gamma detectors | |
US11810685B2 (en) | Early detection of radioisotope generator end life | |
CN112106148B (en) | Early detection of radioisotope generator life | |
EP4107764B1 (en) | Radioisotope generator early breakthrough detection | |
CN112074917B (en) | Systems and techniques for calibrating radioisotope delivery systems with gamma detectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15713107 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2940697 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2015713107 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015713107 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2015229189 Country of ref document: AU Date of ref document: 20150313 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20167025218 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2016140051 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112016020762 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112016020762 Country of ref document: BR Kind code of ref document: A2 Effective date: 20160908 |